Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma.

被引：0
|
作者：
Brewster, Abenaa M.
Lee, J. Jack
Clayman, Gary
Clifford, John
Reyes, Mary Jo Necesito
Zhou, Xian
Sabichi, Anita
Strom, Sara
Collins, Robert
Meyers, Christina
Lippman, Scott
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] LSU Hlth Sci Ctr, Shreveport, LA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5659
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Is 13-CIS-retinoic acid effective in patients with metastatic renal cell carcinoma?
    Karthikeyan, A.
    Kekre, Nitin S.
    INDIAN JOURNAL OF UROLOGY, 2006, 22 (04) : 384 - U89
  • [32] Multicenter phase II trial of interleukin-2, interferon-α, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma
    Stadler, WM
    Kuzel, T
    Dumas, M
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1820 - 1825
  • [33] A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
    A. Thalasila
    Elizabeth Poplin
    J. Shih
    Dmitri Dvorzhinski
    T. Capanna
    S. Doyle-Lindrud
    S. Beers
    S. Goodin
    Eric Rubin
    Robert S. DiPaola
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 119 - 124
  • [34] PHASE-II STUDY OF 13-CIS-RETINOIC ACID AND INTERFERON-ALPHA-2A IN PATIENTS WITH ADVANCED SQUAMOUS-CELL LUNG-CANCER
    RINALDI, DA
    LIPPMAN, SM
    BURRIS, HA
    CHOU, C
    VONHOFF, DD
    HONG, WK
    ANTI-CANCER DRUGS, 1993, 4 (01) : 33 - 36
  • [35] Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma
    Jaremtchuk, AV
    Aman, EF
    Ponce, W
    Zarbá, JJ
    Ferro, AM
    Alvarez, R
    Vigo, SA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (02): : 123 - 125
  • [36] 13-cis retinoic acid and interferon-alpha plus or minus irradiation in the treatment of squamous-cell carcinomas
    Hoffmann, W
    Schiebe, M
    Hirnle, P
    Souchon, R
    Clemens, M
    Adamietz, I
    Bamberg, M
    INTERNATIONAL JOURNAL OF CANCER, 1997, 70 (04) : 475 - 477
  • [37] α-Interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma
    Wong, M
    Goldstein, D
    Woo, H
    Testa, G
    Gurney, H
    INTERNAL MEDICINE JOURNAL, 2002, 32 (04) : 158 - 162
  • [38] Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity
    Dimery, IW
    Hong, WK
    Lee, JJ
    GuilloryPerez, C
    Pham, F
    Fritsche, HA
    Lippman, SM
    ANNALS OF ONCOLOGY, 1997, 8 (01) : 85 - 89
  • [39] 13-CIS-RETINOIC ACID PLUS INTERFERON ALPHA-2A - HIGHLY-ACTIVE SYSTEMIC THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    LIPPMAN, SM
    KAVANAGH, JJ
    PAREDESESPINOZA, M
    DELGADILLOMADRUENO, F
    PAREDESCASILLAS, P
    HONG, WK
    HOLDENER, E
    KRAKOFF, IH
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04): : 241 - 245
  • [40] PHASE-II STUDY OF ALPHA-INTERFERON AND 13-CIS-RETINOIC ACID IN METASTATIC MELANOMA
    DHINGRA, K
    PAPADOPOULOS, N
    LIPPMAN, S
    LOTAN, R
    LEGHA, SS
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) : 39 - 43
12345